Applications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?A conceptual model of the multiple stages of communication necessary to support patient-centered careRole of practice-based research networks in comparative effectiveness researchComparative effectiveness research in chronic obstructive pulmonary diseaseDevelopment, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patientsReconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era.The value of linking hospital discharge and mortality data for comparative effectiveness research.Bayesian data analysis in observational comparative effectiveness research: rationale and examples.Big data, advanced analytics and the future of comparative effectiveness research.Building electronic data infrastructure for comparative effectiveness research: accomplishments, lessons learned and future steps.American Recovery and Reinvestment Act investments in data infrastructure.American Recovery and Reinvestment Act-comparative effectiveness research infrastructure investments: emerging data resources, tools and publications.Comparative effectiveness research and big data: balancing potential with legal and ethical considerations.A national data infrastructure for patient-centered outcomes research.Predictors of preoperative MRI for breast cancer: differences by data source.Using linked electronic data to validate algorithms for health outcomes in administrative databases.Better research reporting to improve the utility of routine data for making better treatment decisions.Using big data for quality assessment in oncology.Using primary care electronic health record data for comparative effectiveness research: experience of data quality assessment and preprocessing in The Netherlands.Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk.Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysisDesign of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancerUse of community-based participatory research in primary care to improve healthcare outcomes and disparities in care.Comparison of evidence-based interventions on outcomes of hospitalized, cognitively impaired older adults.Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.Ventricular assist device use in congenital heart disease with a comparison to heart transplantTying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs.A tall order on a tight timeframe: stakeholder perspectives on comparative effectiveness research using electronic clinical data.Clostridium difficile infection: current, forgotten and emerging treatment options.Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficientAtypical antipsychotics for older adults: are they safe and effective as we once thought?Promoting perioperative advance care planning: a systematic review of advance care planning decision aids.RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma.Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study.Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study.Quality of life and visual acuity outcomes in the Registry in Glaucoma Outcomes Research study.IMPACCT Kids' Care: a real-world example of stakeholder involvement in comparative effectiveness research.Stakeholder participation in comparative effectiveness research: defining a framework for effective engagementComparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settingsObservational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR.
P1433
Q26849372-437EDC72-AE15-4B57-B9B6-50190AFF836FQ26861619-A96853BE-407A-4FDC-A670-323BAF3FA594Q26863245-1609E2C5-E75D-4A39-8308-ECF7666871A8Q26864606-C0A8015C-F974-46A5-B27A-182F2781DDB4Q28250496-0A05FA68-BE7E-4C60-B7C1-BD573326651DQ30276626-347E5868-3A65-48E3-9345-ACE086ABDD19Q30695610-C311BC08-6487-498D-AC50-FBC50BE073F4Q30695644-8B5194F6-19A5-4582-8E88-7DAA6C0E9A3BQ30780769-12A97D3D-732D-4716-8041-D17025F7E488Q30877104-E57B3D5D-FE3F-4013-9250-629FFE5F9137Q30877110-9F0A10BE-3888-4BDF-B501-06AF5372A529Q30877115-21BDDAF8-C9F9-46FE-B4A7-BD8F8A794F0BQ30883073-BC597241-3203-4E0D-A27D-DBA2C8095404Q30883076-996F408A-3AA6-4C82-A90D-86B6A90D0492Q30948683-7B52DF5F-B34C-46FE-B10C-4CB3B1CF6035Q30987366-C2E1507D-898D-4200-BB4A-4538E727F9CAQ31050809-481CFBB7-2EAD-45F2-97E0-00CD9039CF3CQ31080159-76B1C922-51E5-4F2D-92C8-1ABAD4347446Q31110771-0E8315F5-3FA5-4821-9C4E-3E81B165093CQ31147850-58DD8244-7B5D-4DC8-85B2-3951FF0DFF64Q33599906-6F290522-8238-49BD-9FD8-606465E258A8Q33677912-702B595C-E484-41F4-83A5-922F861FC63CQ33702227-6596EED8-3838-4EB1-B852-563ECDD51BAAQ34224586-75141040-95B7-40F4-9EA2-4B868AFF46DDQ34421812-046EB0A0-DE5C-4176-9D9E-FC7B725D3762Q34510391-70EA0AF7-87CF-406B-AB21-0C8C04754B84Q34541147-E11CA27B-D092-4E3A-81E4-D59B4A96EA4AQ35044077-4AA91EC8-6310-4F80-AC68-6E69C5A44950Q35372397-61A6E761-6EAB-4D66-9361-B2C0F82E8F2CQ35541348-30EAECBC-E255-4882-AE92-81532E564CF4Q35565618-2573C423-B438-4C5C-B970-3DE36C215E71Q35766158-4419A176-5CD1-4FA8-BD2F-96E1B74DC93AQ35874576-96D86528-C6BE-4E71-A54F-0DF28118D836Q35874612-19D27DE5-BE30-4CDB-970B-C212538655E7Q35874705-0A059CCC-CE66-43C2-A120-29519AE83D5CQ35874757-C91F36F6-774B-465F-8BF8-F7C986F11119Q35961544-74E6D31A-A109-4CDE-9751-15E9C74C06C2Q36021512-446E3581-CF1B-4C3E-9F17-DF2BBC1C2946Q36031230-436B6CFE-7B37-47AC-879C-BD514E160781Q36338676-C44344BF-63EF-4FC4-9088-59800BCD3CD4
P1433
description
periodiek van uitgeverij Future Medicine
@nl
name
Journal of Comparative Effectiveness Research
@en
type
label
Journal of Comparative Effectiveness Research
@en
prefLabel
Journal of Comparative Effectiveness Research
@en
P243
P3181
P1055
P1156
21100258385
P123
P1277
P236
P243
P31
P3181
P407
P571
2012-01-01T00:00:00Z